 Rebecca Keith
Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Experimental | 2 | 2013 | 147 | 0.690 |
Why?
| | Pulmonary Fibrosis | 4 | 2025 | 400 | 0.600 |
Why?
| | Arthritis, Rheumatoid | 3 | 2017 | 1163 | 0.490 |
Why?
| | Lung Diseases, Interstitial | 3 | 2025 | 634 | 0.470 |
Why?
| | Bleomycin | 4 | 2018 | 247 | 0.320 |
Why?
| | Testosterone | 1 | 2013 | 399 | 0.320 |
Why?
| | Acute Lung Injury | 1 | 2011 | 288 | 0.300 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2019 | 97 | 0.300 |
Why?
| | Autoimmunity | 1 | 2013 | 907 | 0.270 |
Why?
| | Lung Diseases | 1 | 2013 | 768 | 0.260 |
Why?
| | Idiopathic Pulmonary Fibrosis | 3 | 2018 | 653 | 0.230 |
Why?
| | Tomography, X-Ray Computed | 3 | 2025 | 2681 | 0.210 |
Why?
| | Bronchiectasis | 1 | 2024 | 111 | 0.200 |
Why?
| | Lung | 5 | 2014 | 4066 | 0.190 |
Why?
| | Disease Models, Animal | 2 | 2014 | 4295 | 0.190 |
Why?
| | Lactic Acid | 1 | 2022 | 306 | 0.170 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2018 | 8 | 0.150 |
Why?
| | fas Receptor | 3 | 2018 | 95 | 0.150 |
Why?
| | Fatty Acids | 1 | 2022 | 445 | 0.150 |
Why?
| | Lung Compliance | 3 | 2014 | 49 | 0.140 |
Why?
| | Myofibroblasts | 1 | 2018 | 125 | 0.140 |
Why?
| | Cause of Death | 1 | 2019 | 431 | 0.130 |
Why?
| | Mortality | 1 | 2019 | 357 | 0.130 |
Why?
| | Apoptosis | 2 | 2018 | 2557 | 0.130 |
Why?
| | Mice | 7 | 2018 | 17843 | 0.100 |
Why?
| | Collagen | 2 | 2011 | 447 | 0.100 |
Why?
| | Quality of Life | 1 | 2024 | 2870 | 0.100 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2011 | 654 | 0.090 |
Why?
| | Mucin-5B | 1 | 2013 | 224 | 0.090 |
Why?
| | Mice, Mutant Strains | 1 | 2011 | 300 | 0.090 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 324 | 0.090 |
Why?
| | Vital Capacity | 2 | 2025 | 309 | 0.090 |
Why?
| | Macrophages, Alveolar | 1 | 2014 | 392 | 0.090 |
Why?
| | Sex Characteristics | 2 | 2013 | 766 | 0.090 |
Why?
| | Smoke | 1 | 2011 | 144 | 0.080 |
Why?
| | Exercise | 1 | 2022 | 2024 | 0.080 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1271 | 0.080 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1242 | 0.080 |
Why?
| | Lung Injury | 1 | 2011 | 218 | 0.070 |
Why?
| | Up-Regulation | 1 | 2011 | 846 | 0.070 |
Why?
| | Animals | 7 | 2018 | 37011 | 0.070 |
Why?
| | Male | 10 | 2025 | 67718 | 0.070 |
Why?
| | Female | 9 | 2025 | 73162 | 0.070 |
Why?
| | Fibroblasts | 1 | 2011 | 990 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2018 | 3020 | 0.050 |
Why?
| | Survival Analysis | 2 | 2017 | 1320 | 0.050 |
Why?
| | Fever | 1 | 2022 | 307 | 0.040 |
Why?
| | Occupations | 1 | 2019 | 48 | 0.040 |
Why?
| | Middle Aged | 4 | 2025 | 33355 | 0.040 |
Why?
| | Humans | 9 | 2025 | 137514 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2022 | 684 | 0.040 |
Why?
| | Drug Resistance, Microbial | 1 | 2018 | 71 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 77 | 0.040 |
Why?
| | Mice, Transgenic | 2 | 2014 | 2182 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2022 | 511 | 0.040 |
Why?
| | Biopsy, Needle | 1 | 2018 | 191 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2022 | 1059 | 0.040 |
Why?
| | Mice, Inbred C57BL | 3 | 2014 | 5792 | 0.040 |
Why?
| | Forecasting | 1 | 2019 | 386 | 0.030 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2017 | 75 | 0.030 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2017 | 49 | 0.030 |
Why?
| | Reference Values | 1 | 2018 | 821 | 0.030 |
Why?
| | Disease Progression | 1 | 2024 | 2755 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2022 | 780 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 621 | 0.030 |
Why?
| | Rheumatoid Factor | 1 | 2017 | 175 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 658 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1790 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 5730 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4206 | 0.030 |
Why?
| | Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 11 | 0.030 |
Why?
| | Hydroxyproline | 1 | 2014 | 21 | 0.030 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2014 | 28 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1740 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2022 | 15628 | 0.030 |
Why?
| | Mucin 5AC | 1 | 2013 | 70 | 0.030 |
Why?
| | Ear, Middle | 1 | 2013 | 93 | 0.030 |
Why?
| | Remission Induction | 1 | 2014 | 287 | 0.030 |
Why?
| | Aged | 2 | 2025 | 23798 | 0.020 |
Why?
| | Cilia | 1 | 2013 | 186 | 0.020 |
Why?
| | United States | 2 | 2019 | 14696 | 0.020 |
Why?
| | Phagocytosis | 1 | 2013 | 379 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2013 | 251 | 0.020 |
Why?
| | Chemokine CXCL1 | 1 | 2011 | 76 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 59 | 0.020 |
Why?
| | Trauma Severity Indices | 1 | 2011 | 106 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 145 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2018 | 3546 | 0.020 |
Why?
| | Recovery of Function | 1 | 2014 | 662 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 452 | 0.020 |
Why?
| | Smoking | 1 | 2017 | 1639 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 849 | 0.020 |
Why?
| | Adult | 2 | 2022 | 37821 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2011 | 480 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 4031 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1980 | 0.020 |
Why?
| | Models, Biological | 1 | 2013 | 1775 | 0.020 |
Why?
| | Macrophages | 1 | 2013 | 1548 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 1042 | 0.020 |
Why?
| | Cell Line | 1 | 2011 | 2852 | 0.010 |
Why?
| | Sex Factors | 1 | 2011 | 2074 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1770 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2857 | 0.010 |
Why?
| | Age Factors | 1 | 2011 | 3301 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 6817 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2837 | 0.010 |
Why?
| | Asthma | 1 | 2013 | 2290 | 0.010 |
Why?
| | Prospective Studies | 1 | 2011 | 7598 | 0.010 |
Why?
|
|
Keith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|